Gilead Sciences, Inc. - Company Profile and SWOT Analysis

January 2025 | 64 pages | ID: GA4829ED050EN
MarketLine

Abstracts

Gilead Sciences, Inc. - Company Profile and SWOT Analysis

Summary

Gilead Sciences, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under several brand names, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe, and other countries. The company is headquartered in Foster City, California, the US.

Scope

• Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
• Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2021 - 2025YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Divestments
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Financial Deals
Gilead Sciences, Inc.: Financial Performance
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine